NTRK2 and epilepsy: By selectively disrupting pathways downstream or upstream it could be possible to regulate BDNF/TrkB signaling, which would hopefully result in the treatment not only of epilepsy but also of drug-resistant epilepsy, where the use of matrix encapsulated cell lines secreting human BDNF provides an interesting option for patients with drug-resistant TLE [583].